The European Medicines Agency (EMA) publishes a full work programme and annual report, to provide an overview of the work of the Agency together with the European medicines regulatory network.

EMA’s annual reports provide an overview of EMA’s work together with the European medicines regulatory network. They contain:

• key achievements in protecting and promoting public and animal health in the EU;
• reflections by EMA staff and its partners and stakeholders on topics of major interest in medicine and health;
• key figures, including core statistics that highlight the main outcomes of the Agency's activities and interesting trends and changes observed in recent years.

EMA publishes its annual reports in May / June following the year in question.

EMA also publishes information on the volume and outcome of centralised procedures for human and veterinary medicines. For further details, see Medicine evaluation figures.

EMA’s work programmes (now called programming documents) reflect the priorities and main focus areas of EMA and of the European medicines regulatory network for the corresponding period and describe objectives and planned activities. They cover:

• human medicines evaluation activities, split into pre-authorisation, initial evaluation, post-authorisation, pharmacovigilance and referrals;
• veterinary medicines evaluation activities, with a similar structure to the human medicines chapter;
• horizontal activities that enable and support the evaluation of human and veterinary medicines. These include committee coordination, inspections, partner and stakeholder relationship management, and data management;
• corporate governance and support activities, including finance, human resources and quality management.